Annals of Phlebology

Table. 1.

Demographic and treatment characteristics between PA and nPA group in unadjusted data

nPA, n=258 PA, n=329 p
Age, years 56.2±13.8 55.6±14.6 NS
Male sex: no. (%) 120 (46.5%) 171 (52.0%) NS
Calf circumference 36.2±3.3 36.7±3.2 NS
GSV size (mean) 4.84±2.3 5.2±2.4 NS
Recurrence 9 (3.5%) 24 (7.3%) 0.047
Calf circumference 36.40±3.2 36.37±3.0 NS
Diabetes 26 (10.1%) 17 (7.5%) NS
PAOD 4 (1.6%) 5 (1.5%) NS
Combined SSV treatment 117 (45.3%) 145 (44.1%) NS
No. Of CVD related complication 75 (29.1%) 129 (39.2%) 0.01
Main Endovenous Procedure
VenaSealTM 13 (5%) 14 (14.0%) 0.001
RFA 110 (42.6%) 96 (29.2%) 0.001
EVLT 08 (41.9%) 142 (43.2%) NS
UGFS 27 (10.5%) 45 (13.7%) NS
No. Of phlebectomy 3.27±2.3 4.04±2.96 0.001
CEAP Clinical Class
0 18 (7.0%) 16 (4.9%) 0.113
1 5 (1.9%) 16 (4.9%)
2 166 (64.3%) 199 (60.5%)
3 35 (13.6%) 37 (11.2%)
4 34 (13.2%) 57 (17.3%)
5 0 1 (0.3%)
6 0 3 (0.9%)

GSV: great saphenous vein, SSV: small saphenous vein, PAOD: peripheral arterial occlusive disease, CVD: chronic venous disease, RFA: radio frequency ablation, EVLT: endo venous laser ablation, UGFS: ultrasonography guided foam sclerotherapy.

Ann Phlebology 2022;20:30~36 https://doi.org/10.37923/phle.2022.20.1.30
© Ann Phlebology